Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance
- PMID: 40215978
- PMCID: PMC12151758
- DOI: 10.1016/j.ccell.2025.03.031
Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance
Abstract
Cuproptosis is a recently identified form of copper-dependent cell death. Here, we reveal that radiotherapy (RT) induces cuproptosis in cancer cells, independent of apoptosis and ferroptosis, and depletes lipoylated proteins and iron-sulfur (Fe-S) cluster proteins-both hallmarks of cuproptosis-in patient tumors. Mechanistically, RT elevates mitochondrial copper levels by upregulating copper transporter 1 (CTR1) and depleting mitochondrial glutathione, a copper chelator, thereby triggering cuproptosis. Integrated analyses of RNA sequencing (RNA-seq) from radioresistant esophageal cancer cells and single-cell RNA-seq from esophageal tumors of patients unresponsive to RT link radioresistance to the downregulation of BTB and CNC homology 1 (BACH1). This downregulation de-represses the expression of copper-sequestering metallothionein (MT) 1E/X, thereby mitigating cuproptosis and contributing to radioresistance. Copper ionophore treatment sensitizes radioresistant cancer cells and cell line- and patient-derived xenografts to RT by potentiating cuproptosis. Our findings unveil a link between RT and cuproptosis and inform a therapeutic strategy to overcome tumor radioresistance by targeting cuproptosis.
Keywords: copper; cuproptosis; metallothionein; radioresistance; radiotherapy.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests B.G., G.L., and J.C. have filed a patent for the use of cuproptosis inducers to overcome radioresistance in cancer treatment.
Similar articles
-
Cuproptosis: a novel therapeutic mechanism in lung cancer.Cancer Cell Int. 2025 Jun 24;25(1):231. doi: 10.1186/s12935-025-03864-1. Cancer Cell Int. 2025. PMID: 40555995 Free PMC article. Review.
-
Role of PLEKHA7 in promoting radioresistance in esophageal cancer cells via the inhibition of cuproptosis.J Thorac Dis. 2025 Jun 30;17(6):4219-4237. doi: 10.21037/jtd-2025-858. Epub 2025 Jun 23. J Thorac Dis. 2025. PMID: 40688283 Free PMC article.
-
AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5.Cell Death Dis. 2025 Jul 2;16(1):483. doi: 10.1038/s41419-025-07773-z. Cell Death Dis. 2025. PMID: 40603306 Free PMC article.
-
Targeting the TRIM14/USP14 axis enhances radiotherapy efficacy by inducing GPX4 degradation and disrupting ferroptotic defense in HCC.Cell Death Dis. 2025 Jul 1;16(1):481. doi: 10.1038/s41419-025-07807-6. Cell Death Dis. 2025. PMID: 40595451 Free PMC article.
-
Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma.J Cancer Res Clin Oncol. 2023 Dec;149(19):17663-17670. doi: 10.1007/s00432-023-05456-w. Epub 2023 Oct 16. J Cancer Res Clin Oncol. 2023. PMID: 37843555 Free PMC article. Review.
Cited by
-
Cuproptosis: a novel therapeutic mechanism in lung cancer.Cancer Cell Int. 2025 Jun 24;25(1):231. doi: 10.1186/s12935-025-03864-1. Cancer Cell Int. 2025. PMID: 40555995 Free PMC article. Review.
-
Engineered anti-cancer nanomedicine for synergistic cuproptosis-immunotherapy.Mater Today Bio. 2025 Jul 29;34:102133. doi: 10.1016/j.mtbio.2025.102133. eCollection 2025 Oct. Mater Today Bio. 2025. PMID: 40791799 Free PMC article. Review.
-
Bioactive LDH nanoplatforms for cancer therapy: Advances in modulating programmed cell death.Mater Today Bio. 2025 Jul 26;34:102139. doi: 10.1016/j.mtbio.2025.102139. eCollection 2025 Oct. Mater Today Bio. 2025. PMID: 40761508 Free PMC article. Review.
-
Transcriptional regulation of cuproptosis resistance in cancer therapy.Trends Cancer. 2025 Aug;11(8):713-715. doi: 10.1016/j.trecan.2025.06.006. Epub 2025 Jun 25. Trends Cancer. 2025. PMID: 40571556
References
-
- Adjemian S, Oltean T, Martens S, Wiernicki B, Goossens V, Vanden Berghe T, Cappe B, Ladik M, Riquet FB, Heyndrickx L, et al. (2020). Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death. Cell Death Dis 11, 1003. 10.1038/s41419-020-03209-y. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous